GlassScriptPhysician profile
Zamip P Patel
NPI 1437318326
$22,064.11
in general payments reported to CMS, 2019-2025
32 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $572 · 2021: $2,686 · 2022: $1,596 · 2023: $1,179 · 2024: $4,069 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,435 · Consulting Fee: $3,333 · Food and Beverage: $2,364 · Travel and Lodging: $1,768 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,435.04 |
| Consulting Fee | $3,333.00 |
| Food and Beverage | $2,363.76 |
| Travel and Lodging | $1,767.90 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,615.01 | 2020-2025 | |
| Stryker Corporation | $2,500.00 | 2025 | |
| Galen US INC | $1,500.00 | 2021 | |
| Valencia Technologies Corporation | $1,020.86 | 2022-2024 | Ecoin Device Kit |
| Boston Scientific Corporation | $860.45 | 2019-2025 | Axonics |
| Procept Biorobotics Corporation | $846.53 | 2021-2023 | Aquabeam Robotic System |
| Becton, Dickinson and Company | $833.00 | 2025 | |
| Coloplast Corp | $678.41 | 2019-2025 | Titan |
| Astellas Pharma US INC | $410.75 | 2021-2024 | Xtandi |
| Teleflex LLC | $299.98 | 2021-2025 | Barrigel, Urolift |
| Medtronic USA, INC. | $221.03 | 2020 | |
| Axonics, INC. | $216.33 | 2021-2023 | Axonics |
| Karl Storz Endoscopy-America | $165.70 | 2021 | |
| Medtronic, INC. | $144.52 | 2024-2025 | Signia, Interstim |
| Neotract INC. | $125.23 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $110.00 | 2019 | |
| Endo Pharmaceuticals INC. | $104.51 | 2022-2023 | Xiaflex, Aveed |
| Innovation Technologies INC | $68.20 | 2025 | Irrisept |
| Endo USA, INC. | $61.79 | 2024 | Xiaflex |
| Alexion Pharmaceuticals, INC. | $55.43 | 2025 | Ultomiris |
| Accord Healthcare, INC. | $29.75 | 2023 | |
| Amgen INC. | $28.39 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.72 | 2023 | |
| Olympus America INC. | $21.71 | 2024 | Itind System |
| Agiliti Surgical, INC. | $21.12 | 2025 | Koelis Trinity Mri/US Fusion |
| Laborie Medical Technologies Corp. | $19.68 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $15.43 | 2025 | |
| Janssen Biotech, INC. | $14.98 | 2021 | |
| Antares Pharma, INC. | $14.36 | 2022 | |
| Surgenex LLC | $13.57 | 2025 | Surgraft, Ardeograft, Renograft |
| Tolmar, INC. | $13.17 | 2023 | |
| Clarus Therapeutics INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,100,012.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zamip Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.